90 related articles for article (PubMed ID: 9190840)
1. Bioavailability, antinociceptive and antiinflammatory properties of BP 2-94, a histamine H3 receptor agonist prodrug.
Rouleau A; Garbarg M; Ligneau X; Mantion C; Lavie P; Advenier C; Lecomte JM; Krause M; Stark H; Schunack W; Schwartz JC
J Pharmacol Exp Ther; 1997 Jun; 281(3):1085-94. PubMed ID: 9190840
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory and antinociceptive properties of BP 2-94, a histamine H(3)-receptor agonist prodrug.
Rouleau A; Stark H; Schunack W; Schwartz JC
J Pharmacol Exp Ther; 2000 Oct; 295(1):219-25. PubMed ID: 10991982
[TBL] [Abstract][Full Text] [Related]
3. S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.
Garbarg M; Arrang JM; Rouleau A; Ligneau X; Tuong MD; Schwartz JC; Ganellin CR
J Pharmacol Exp Ther; 1992 Oct; 263(1):304-10. PubMed ID: 1383495
[TBL] [Abstract][Full Text] [Related]
4. Gastric antisecretory effects of compound BP 2-94: a histamine H3-receptor agonist prodrug.
Soldani G; Bertini S; Rouleau A; Schwartz JC; Coruzzi G
Dig Dis Sci; 1999 Dec; 44(12):2380-5. PubMed ID: 10630485
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of BP 2-94, a histamine H3-receptor agonist prodrug, in a model of carbon tetrachloride-induced hepatotoxicity in rats.
Valcheva-Kuzmanova SV; Popova PB; Krasnaliev IJ; Galunska BT; Belcheva A; Schunack W
Folia Med (Plovdiv); 2004; 46(2):36-41. PubMed ID: 15506549
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
McLeod RL; Rizzo CA; West RE; Aslanian R; McCormick K; Bryant M; Hsieh Y; Korfmacher W; Mingo GG; Varty L; Williams SM; Shih NY; Egan RW; Hey JA
J Pharmacol Exp Ther; 2003 Jun; 305(3):1037-44. PubMed ID: 12649305
[TBL] [Abstract][Full Text] [Related]
7. Sch 50971, an orally active histamine H3 receptor agonist, inhibits central neurogenic vascular inflammation and produces sedation in the guinea pig.
McLeod RL; Aslanian R; del Prado M; Duffy R; Egan RW; Kreutner W; McQuade R; Hey JA
J Pharmacol Exp Ther; 1998 Oct; 287(1):43-50. PubMed ID: 9765320
[TBL] [Abstract][Full Text] [Related]
8. Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist.
Ligneau X; Lin J; Vanni-Mercier G; Jouvet M; Muir JL; Ganellin CR; Stark H; Elz S; Schunack W; Schwartz J
J Pharmacol Exp Ther; 1998 Nov; 287(2):658-66. PubMed ID: 9808693
[TBL] [Abstract][Full Text] [Related]
9. Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats.
Medhurst AD; Briggs MA; Bruton G; Calver AR; Chessell I; Crook B; Davis JB; Davis RP; Foley AG; Heslop T; Hirst WD; Medhurst SJ; Ociepka S; Ray A; Regan CM; Sargent B; Schogger J; Stean TO; Trail BK; Upton N; White T; Orlek B; Wilson DM
Biochem Pharmacol; 2007 Apr; 73(8):1182-94. PubMed ID: 17276409
[TBL] [Abstract][Full Text] [Related]
10. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
[TBL] [Abstract][Full Text] [Related]
11. Synergistic interaction between fentanyl and the histamine H3 receptor agonist R-(alpha)-methylhistamine, on the inhibition of nociception and plasma extravasation in mice.
Poveda R; Fernández-Dueñas V; Fernández A; Sánchez S; Puig MM; Planas E
Eur J Pharmacol; 2006 Jul; 541(1-2):53-6. PubMed ID: 16762339
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro pharmacology of a series of new chiral histamine H3-receptor ligands: 2-(R and S)-Amino-3-(1H-imidazol-4(5)-yl)propyl ether derivatives.
Kovalainen JT; Christiaans JA; Kotisaari S; Laitinen JT; Männistö PT; Tuomisto L; Gynther J
J Med Chem; 1999 Apr; 42(7):1193-202. PubMed ID: 10197963
[TBL] [Abstract][Full Text] [Related]
13. In vivo demonstration of H3-histaminergic inhibition of cardiac sympathetic stimulation by R-alpha-methyl-histamine and its prodrug BP 2.94 in the dog.
Mazenot C; Ribuot C; Durand A; Joulin Y; Demenge P; Godin-Ribuot D
Br J Pharmacol; 1999 Jan; 126(1):264-8. PubMed ID: 10051144
[TBL] [Abstract][Full Text] [Related]
14. Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects.
Esbenshade TA; Krueger KM; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Fox GB; Faghih R; Bennani YL; Williams M; Hancock AA
J Pharmacol Exp Ther; 2003 Jun; 305(3):887-96. PubMed ID: 12606603
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist.
Esbenshade TA; Fox GB; Krueger KM; Baranowski JL; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Pan JB; Faghih R; Bennani YL; Williams M; Hancock AA
Biochem Pharmacol; 2004 Sep; 68(5):933-45. PubMed ID: 15294456
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, X-ray crystallography, and pharmacokinetics of novel azomethine prodrugs of (R)-alpha-methylhistamine: highly potent and selective histamine H3 receptor agonists.
Krause M; Rouleau A; Stark H; Luger P; Lipp R; Garbarg M; Schwart JC; Schunack W
J Med Chem; 1995 Sep; 38(20):4070-9. PubMed ID: 7562942
[TBL] [Abstract][Full Text] [Related]
17. Effects of (R)-alpha-methylhistamine and its prodrug BP 2.94 on gastric mucosal lesions in cold/restraint stressed rats.
Belcheva A; Marazova K; Lozeva V; Schunack W
Inflamm Res; 1997 Mar; 46 Suppl 1():S113-4. PubMed ID: 9098792
[No Abstract] [Full Text] [Related]
18. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like effects of endogenous histamine and of two histamine H1 receptor agonists in the mouse forced swim test.
Lamberti C; Ipponi A; Bartolini A; Schunack W; Malmberg-Aiello P
Br J Pharmacol; 1998 Apr; 123(7):1331-6. PubMed ID: 9579727
[TBL] [Abstract][Full Text] [Related]
20. BP-294 Ste Civile Bioprojet.
Fozard JR
Curr Opin Investig Drugs; 2000 Sep; 1(1):86-9. PubMed ID: 11249601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
